Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Pidilizumab |
Trade Name | |
Synonyms | CT 011|CT-011|MDV9300 |
Drug Descriptions |
Pidilizumab (CT 011) is a monoclonal antibody that targets PD-1 (PDCD1) and inhibits binding of the PD-L1 (CD274) ligand, potentially resulting in enhanced anti-tumor immune response (PMID: 29143272). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | 1036730-42-3 |
NCIT ID | C71014 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Lenalidomide + Pidilizumab | Lenalidomide Pidilizumab | 0 | 1 |
Pidilizumab | Pidilizumab | 0 | 1 |